Christina Ackermann - 01 Sep 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Christina M. Ackermann
Issuer symbol
VRNA
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
4
Filing time
05 Sep 2023, 16:05:37 UTC
Previous filing
27 Mar 2023
Next filing
30 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Options (Right to Buy) Award $0 +144,000 $0.000000 144,000 01 Sep 2023 Ordinary Shares 144,000 $2.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The option vests and becomes exercisable as to one-third of the underlying options on September 1, 2024 and the remainder in eight equal quarterly installments over the two years thereafter.